Dare Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-28.8M | $-28.8M | $14.5K | $1.6M |
| FY2022 | $-18.1M | $-18.2M | $63.1K | $2.2M |
| FY2023 | $-38.9M | $-39.5M | $629.4K | $2.5M |
| FY2024 | $5.5M | $4.9M | $573.0K | $2.2M |
| FY2025 | $-9.9M | $-10.3M | $385.3K | $1.5M |